A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
PHASE3
Study GO43104 is a Phase III, randomized, open-label, multicenter study of ...
Status
Active Not Recruiting
Location
Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
PHASE2
This study will evaluate the surgical safety and feasibility of atezolizuma...
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE3
This is a Phase III, global, double-blind, 2-arm randomized study designed ...